Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Guchelaar HJ"'
Autor:
Samarasinghe SR; Centre for Genomics and Personalised Health, Queensland University of Technology, Brisbane, QLD, Australia., Hoy W; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia., Jadhao S; Centre for Genomics and Personalised Health, Queensland University of Technology, Brisbane, QLD, Australia., McMorran BJ; John Curtin School of Medical Research, College of Health and Medicine, Australian National University, Canberra, ACT, Australia., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Nagaraj SH; Centre for Genomics and Personalised Health, Queensland University of Technology, Brisbane, QLD, Australia.; Translational Research Institute, Queensland University of Technology, Brisbane, QLD, Australia.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2023 May 22; Vol. 14, pp. 1180640. Date of Electronic Publication: 2023 May 22 (Print Publication: 2023).
Autor:
Hurkmans EGE; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands., Klumpers MJ; Department of Pediatrics, Radboud University Medical Center, Nijmegen, Netherlands., Dello Russo C; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology (ISMIB), University of Liverpool, Liverpool, United Kingdom.; Department of Healthcare Surveillance and Bioethics, Section of Pharmacology, Università Cattolica del Sacro Cuore-Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., De Witte W; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands., Guchelaar HJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., Cleton-Jansen AM; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands., Vermeulen SH; Department for Health Evidence, Radboud University Medical Center, Nijmegen, Netherlands., Kaal S; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands., van der Graaf WTA; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Flucke U; Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands., Gidding CEM; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., Schreuder HWB; Department of Orthopedics, Radboud University Medical Center, Nijmegen, Netherlands., de Bont ESJM; Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, Netherlands., Caron HN; Department of Pediatrics, Amsterdam University Medical Centers, Emma Children's Hospital, Amsterdam, Netherlands., Gattuso G; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Schiavello E; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Terenziani M; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Massimino M; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., McCowage G; Cancer Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia., Nagabushan S; Cancer Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia.; Discipline of Child and Adolescent Health, University of Sydney, Sydney, NSW, Australia., Limaye A; Department of Audiology, The Children's Hospital at Westmead, Sydney, NSW, Australia., Rose V; Department of Neuro-Otology, Royal Prince Alfred Hospital, University of Sydney, Sydney, NSW, Australia., Catchpoole D; Children's Cancer Research Unit, The Children's Hospital at Westmead, Sydney, NSW, Australia., Jorgensen AL; Department of Health Data Science, University of Liverpool, Liverpool, United Kingdom., Barton C; Department of Women's and Children's Health, University of Liverpool, Liverpool, United Kingdom., Delaney L; Department of Women's and Children's Health, University of Liverpool, Liverpool, United Kingdom., Hawcutt DB; Department of Women's and Children's Health, University of Liverpool, Liverpool, United Kingdom.; NIHR Alder Hey Clinical Research Facility, Alder Hey Children's Hospital, Liverpool, United Kingdom., Pirmohamed M; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom., Pizer B; Department of Pediatric Oncology, Alder Hey Children's Hospital, Liverpool, United Kingdom., Coenen MJH; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands., Te Loo DMWM; Department of Pediatrics, Radboud University Medical Center, Nijmegen, Netherlands.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2023 Jan 09; Vol. 13, pp. 980309. Date of Electronic Publication: 2023 Jan 09 (Print Publication: 2022).
Autor:
Manson LEN; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Chan PCY; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Böhringer S; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2022 Nov 21; Vol. 13, pp. 1061419. Date of Electronic Publication: 2022 Nov 21 (Print Publication: 2022).
Autor:
Hurkmans EGE; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands., Koenderink JB; Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, Netherlands., van den Heuvel JJMW; Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, Netherlands., Versleijen-Jonkers YMH; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands., Hillebrandt-Roeffen MHS; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands., Groothuismink JM; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands., Vos HI; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands., van der Graaf WTA; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Flucke U; Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands., Muradjan G; Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, Netherlands., Schreuder HWB; Department of Orthopedics, Radboud University Medical Center, Nijmegen, Netherlands., Hagleitner MM; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., Brunner HG; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., Cleton-Jansen AM; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands., Guchelaar HJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, Netherlands., de Bont ESJM; Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, Netherlands., Touw DJ; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, Netherlands., Nijhoff GJ; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, Netherlands., Kremer LCM; Department of Pediatrics, Amsterdam University Medical Centers, Emma Children's Hospital, Amsterdam, Netherlands., Caron H; Department of Pediatrics, Amsterdam University Medical Centers, Emma Children's Hospital, Amsterdam, Netherlands., Windsor R; Pediatric & Adolescent Division, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Patiño-García A; Department of Pediatrics, Clínica Universidad de Navarra, Solid Tumor Program, CIMA, Pamplona, Spain., González-Neira A; Human Genotyping Unit-CeGen, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Saletta F; Children's Cancer Research Unit, The Children's Hospital at Westmead, Sydney, NSW, Australia., McCowage G; Cancer Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia., Nagabushan S; Cancer Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia.; Discipline of Child and Adolescent Health, University of Sydney, Sydney, NSW, Australia., Catchpoole D; Children's Cancer Research Unit, The Children's Hospital at Westmead, Sydney, NSW, Australia., Te Loo DMWM; Department of Pediatrics, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, Netherlands., Coenen MJH; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2022 Nov 09; Vol. 13, pp. 1042989. Date of Electronic Publication: 2022 Nov 09 (Print Publication: 2022).
Autor:
van der Wouden CH; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, Netherlands., Marck H; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, Netherlands., Guchelaar HJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, Netherlands., Swen JJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, Netherlands., van den Hout WB; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2022 Jun 28; Vol. 13, pp. 918493. Date of Electronic Publication: 2022 Jun 28 (Print Publication: 2022).
Autor:
van Laar SA; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Gombert-Handoko KB; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Groenwold RHH; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands., van der Hulle T; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., Visser LE; Department of Hospital Pharmacy, Haga Teaching Hospital, The Hague, Netherlands.; Department of Epidemiology, Erasmus MC, Rotterdam, Netherlands.; Department of Hospital Pharmacy, Erasmus MC, Rotterdam, Netherlands., Houtsma D; Department of Internal Medicine, Haga Teaching Hospital, The Hague, Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Zwaveling J; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2022 Mar 23; Vol. 13, pp. 803935. Date of Electronic Publication: 2022 Mar 23 (Print Publication: 2022).
Autor:
van der Stoep MYEC; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Oostenbrink LVE; Willem-Alexander Children's Hospital, Department of Pediatrics, Leiden University Medical Center, Leiden, Netherlands., Bredius RGM; Willem-Alexander Children's Hospital, Department of Pediatrics, Leiden University Medical Center, Leiden, Netherlands., Moes DJAR; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Zwaveling J; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Lankester AC; Willem-Alexander Children's Hospital, Department of Pediatrics, Leiden University Medical Center, Leiden, Netherlands.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2022 Mar 07; Vol. 13, pp. 826004. Date of Electronic Publication: 2022 Mar 07 (Print Publication: 2022).
Autor:
Visser CD; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Linthorst JM; Royal Dutch Pharmacists Association (KNMP), The Hague, Netherlands., Kuipers E; Community Pharmacy Empel, 's-Hertogenbosch, Netherlands., Sont JK; Department of Biomedical Data Sciences, Section Medical Decision Making, Leiden University Medical Center, Leiden, Netherlands., Lacroix JPW; Department of Digital Engagement, Behavior and Cognition, Philips Research, Eindhoven, Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Teichert M; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands.; Royal Dutch Pharmacists Association (KNMP), The Hague, Netherlands.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2021 Dec 22; Vol. 12, pp. 767092. Date of Electronic Publication: 2021 Dec 22 (Print Publication: 2021).
Autor:
Tafazoli A; Department of Analysis and Bioanalysis of Medicines, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Bialystok, Bialystok, Poland.; Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands.; Leiden Network of Personalized Therapeutics, Leiden, Netherlands., Miltyk W; Department of Analysis and Bioanalysis of Medicines, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Bialystok, Bialystok, Poland., Kretowski AJ; Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland.; Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland., Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands.; Leiden Network of Personalized Therapeutics, Leiden, Netherlands.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2021 Aug 25; Vol. 12, pp. 693453. Date of Electronic Publication: 2021 Aug 25 (Print Publication: 2021).
Autor:
Hulshof EC; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Lim L; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., de Hingh IHJT; Department of Surgical Oncology, Catharina Hospital, Eindhoven, Netherlands.; GROW, School for Oncology and Development Biology, Maastricht University, Maastricht, Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands.; Leiden Network for Personalized Therapeutics, Leiden, Netherlands., Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2020 Oct 06; Vol. 11, pp. 577968. Date of Electronic Publication: 2020 Oct 06 (Print Publication: 2020).